Dr Reddys Laboratories share price

ABOUT Dr Reddys Laboratories

• Industry Biotechnology & Drugs
• ISIN INE089A01023
• BSE Code 500124
• NSE Code DRREDDY

Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The Company’s segments include Pharmaceutical Services and Active Ingredients, Global Generics, and Others. The Pharmaceutical Services and Active Ingredients segment primarily consists of the Company’s business of manufacturing and marketing APIs and intermediates. The Global Generics segment consists of the Company’s business of manufacturing and marketing prescription and OTC finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics).

Dr Reddys Laboratories Management

• Kallam Reddy Chairman of the Board
• Gunupati Prasad Co-Chairman of the Board, Managing Director
• Erez Israeli Chief Executive Officer
• Parag Agarwal Chief Financial Officer
• Patrick Aghanian Chief Executive Officer, European Generics
• Marc Kikuchi Chief Executive Officer, North America Generics
• M. Ramana Chief Executive Officer, Branded Markets (India and Emerging Markets)
• Deepak Sapra Chief Executive Officer, API and Services
• Archana Bhaskar Chief Human Resource Officer
• Phanimitra B. Chief Information Officer